Sponsor Pipeline

Glycomine, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Phase 3
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-15 NCT06892288
A Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participants With…		 date change Primary completion moved earlier: 2026-09-30 -> 2026-08-05
Active Trials by Phase
Phase 2/3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT06892288 A Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participants With… Phosphomannomutase 2 Deficiency Active, Not Recruiting
Phase 2
NCT06657859 Open-Label Extension Study to Assess GLM101 in PMM2-CDG Patients Pmm2-CDG Enrolling by Invitation
Get alerts when Glycomine, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free